NRC Health (NRC) stock
NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/3080% above fair value
$25.89−0.44 (-1.69%)
Close on Nov 17, 2026Market cap $572.56MP/E –Yield 2.01%
NRC Health total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
NRC Health's total debt was $90.03M at Jun 30, 2026. For fiscal 2025 it was $79.04M, up 36.5% from the year before. Over ten years it grew 30.0% a year on average. The highest annual figure on record is $79.04M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $79.04M | +36.5% |
| FY2024 | Dec 31, 2024 | $57.90M | +96.5% |
| FY2023 | Dec 31, 2023 | $29.47M | +66.6% |
| FY2022 | Dec 31, 2022 | $17.69M | -20.6% |
| FY2021 | Dec 31, 2021 | $22.27M | -16.1% |
| FY2020 | Dec 31, 2020 | $26.55M | -10.9% |
| FY2019 | Dec 31, 2019 | $29.80M | -12.8% |
| FY2018 | Dec 31, 2018 | $34.18M | +3103.0% |
| FY2017 | Dec 31, 2017 | $1.07M | -69.9% |
| FY2016 | Dec 31, 2016 | $3.54M | -38.3% |
| FY2015 | Dec 31, 2015 | $5.74M | -28.9% |
| FY2014 | Dec 31, 2014 | $8.07M | -21.9% |
| FY2013 | Dec 31, 2013 | $10.32M | -17.0% |
| FY2012 | Dec 31, 2012 | $12.44M | -1.5% |
| FY2011 | Dec 31, 2011 | $12.63M | -11.9% |
| FY2010 | Dec 31, 2010 | $14.33M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $90.03M | +16.9% |
| Q1 FY2026 | Mar 31, 2026 | $74.02M | +26.2% |
| Q4 FY2025 | Dec 31, 2025 | $79.04M | +36.5% |
| Q3 FY2025 | Sep 30, 2025 | $76.03M | +69.3% |
| Q2 FY2025 | Jun 30, 2025 | $77.03M | +200.2% |
| Q1 FY2025 | Mar 31, 2025 | $58.67M | +112.8% |
| Q4 FY2024 | Dec 31, 2024 | $57.90M | +96.5% |
| Q3 FY2024 | Sep 30, 2024 | $44.91M | +217.1% |
| Q2 FY2024 | Jun 30, 2024 | $25.66M | +67.0% |
| Q1 FY2024 | Mar 31, 2024 | $27.57M | +66.8% |
| Q4 FY2023 | Dec 31, 2023 | $29.47M | +66.6% |
| Q3 FY2023 | Sep 30, 2023 | $14.16M | -24.8% |
| Q2 FY2023 | Jun 30, 2023 | $15.36M | -23.4% |
| Q1 FY2023 | Mar 31, 2023 | $16.53M | -21.9% |
| Q4 FY2022 | Dec 31, 2022 | $17.69M | -20.6% |
| Q3 FY2022 | Sep 30, 2022 | $18.84M | -19.4% |
| Q2 FY2022 | Jun 30, 2022 | $20.04M | -18.0% |
| Q1 FY2022 | Mar 31, 2022 | $21.16M | -17.0% |
| Q4 FY2021 | Dec 31, 2021 | $22.27M | -16.1% |
| Q3 FY2021 | Sep 30, 2021 | $23.36M | -15.3% |
| Q2 FY2021 | Jun 30, 2021 | $24.43M | -14.6% |
| Q1 FY2021 | Mar 31, 2021 | $25.49M | -10.8% |
| Q4 FY2020 | Dec 31, 2020 | $26.55M | -10.9% |
| Q3 FY2020 | Sep 30, 2020 | $27.58M | -11.0% |
| Q2 FY2020 | Jun 30, 2020 | $28.63M | -10.9% |
| Q1 FY2020 | Mar 31, 2020 | $28.59M | -13.9% |
| Q4 FY2019 | Dec 31, 2019 | $29.80M | -12.8% |
| Q3 FY2019 | Sep 30, 2019 | $30.98M | -11.8% |
| Q2 FY2019 | Jun 30, 2019 | $32.14M | -10.8% |
| Q1 FY2019 | Mar 31, 2019 | $33.22M | +3013.7% |
| Q4 FY2018 | Dec 31, 2018 | $34.18M | +15089.3% |
| Q3 FY2018 | Sep 30, 2018 | $35.11M | +891.8% |
| Q2 FY2018 | Jun 30, 2018 | $36.03M | +2326.2% |
| Q4 FY2017 | Dec 31, 2017 | $1.07M | – |
| Q1 FY2017 | Mar 31, 2017 | $225.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $3.54M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.49M | – |
See a number that looks wrong?